# Pill-in-the-POCKET Oral Anticoagulation Strategy After AF Catheter Ablation

> **NCT06216769** · NA · RECRUITING · sponsor: **Seoul National University Hospital** · enrollment: 400 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Rivaroxaban

## Key facts

- **NCT ID:** NCT06216769
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-01
- **Primary completion:** 2030-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06216769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06216769, "Pill-in-the-POCKET Oral Anticoagulation Strategy After AF Catheter Ablation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06216769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*